Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
BACKGROUND
We have previously shown that hyperforin, a phloroglucinol derivative found in St. John's wort, behaves as a potent anti-angiogenic compound. To identify the reactive group(s) mainly involved in this anti-angiogenic effect, we have investigated the anti-angiogenic properties of a series of stable derivatives obtained by oxidative modification of the natural product. In addition, in the present work we have studied the role of the four carbonyl groups present in hyperforin by investigating the potential of some other chemically stable derivatives.


RESULTS
The experimental procedures included the analysis of the effects of treatment of endothelial cells with these compounds in cell growth, cell viability, cell migration and zymographic assays, as well as the tube formation assay on Matrigel. Our study with hyperforin and eight derivatives shows that the enolized beta-dicarbonyl system contained in the structure of hyperforin has a dominant role in its antiangiogenic activity. On the other hand, two of the tested hyperforin derivatives, namely, tetrahydrohyperforin and octahydrohyperforin, behave as potent inhibitors of angiogenesis. Additional characterization of these compounds included a cell specificity study of their effects on cell growth, as well as the in vivo Matrigel plug assay.


CONCLUSIONS
These observations could be useful for the rational design and chemical synthesis of more effective hyperforin derivatives as anti-angiogenic drugs. Altogether, the results indicate that octahydrohyperforin is a more specific and slightly more potent antiangiogenic compound than hyperforin.
Departamento de Biología Molecular y Bioquímica, Facultad de Ciencias, Universidad de Málaga, Málaga, Spain.
Beatriz
B
Martínez-Poveda
Luisella
L
Verotta
Ezio
E
Bombardelli
Ana R
AR
Quesada
Miguel Angel
MA
Medina
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000737:chemistry / Q000494:pharmacology; D002244:Carbon / Q000737:chemistry; D002417:Cattle; D042783:Endothelial Cells / Q000166:cytology; D006801:Humans; D020128:Inhibitory Concentration 50; D051379:Mice; D041681:NIH 3T3 Cells; D009389:Neovascularization, Pathologic; D010100:Oxygen / Q000737:chemistry; D010696:Phloroglucinol / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D013729:Terpenes / Q000737:chemistry / Q000494:pharmacology*
D020533:Angiogenesis Inhibitors; D001643:Bridged Bicyclo Compounds; D013729:Terpenes; D002244:Carbon; D010696:Phloroglucinol; C001654:hyperforin; D010100:Oxygen